LBDRX
Price
$23.10
Change
+$0.04 (+0.17%)
Updated
Jun 18 closing price
Net Assets
110.84M
RMFCX
Price
$62.40
Change
+$0.29 (+0.47%)
Updated
Jun 18 closing price
Net Assets
116.64B
Interact to see
Advertisement

LBDRX vs RMFCX

LBDRX vs RMFCX Comparison Chart in %
View a ticker or compare two or three
VS
LBDRX vs. RMFCX commentary
Jun 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LBDRX is a Hold and RMFCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 117B vs. LBDRX (111M). LBDRX pays higher dividends than RMFCX: LBDRX (1.37) vs RMFCX (1.19). LBDRX was incepted earlier than RMFCX: LBDRX (12 years) vs RMFCX (24 years). LBDRX (1.55) is less costly to investors than RMFCX (0.91). LBDRX is a more actively managed with annual turnover of: 57.00 vs. RMFCX (30.00). LBDRX has a lower initial minimum investment than RMFCX: LBDRX (0) vs RMFCX (250). LBDRX annual gain was more profitable for investors over the last year : 15.02 vs. RMFCX (9.83). RMFCX return over 5 years is better than : 37.65 vs. LBDRX (13.28).
LBDRXRMFCXLBDRX / RMFCX
Total Expense Ratio1.410.91155%
Annual Report Gross Expense Ratio1.550.91170%
Fund Existence12 years24 years-
Gain YTD11.1866.180181%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets111M117B0%
Annual Yield % from dividends1.371.19115%
Returns for 1 year15.029.83153%
Returns for 3 years35.5032.47109%
Returns for 5 years13.2837.6535%
Returns for 10 years44.2493.7047%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IAFLX21.92-0.18
-0.81%
F/m Investments Large Cap Focused Inst
FDNRX189.89-1.70
-0.89%
Franklin DynaTech R
CDEYX20.91-0.20
-0.95%
Columbia Intrinsic Value Institutional 3
GRINX24.79-0.24
-0.96%
Victory Diversified Stock R
GSUSX53.27-0.69
-1.28%
Goldman Sachs US Equity Insights C